Previous studies show that the density and distribution of tumor-infiltrating lymphocytes (TILs) have a significant impact on the prognosis of patients with various types of carcinoma.14-16 Furthermore, the antitumor immune response is strongly mediated by TILs, especially by CD8+ cytotoxic T lymphocytes.11,17. The gene discussed is CD8A; the disease is carcinoma.